XML 30 R7.htm IDEA: XBRL DOCUMENT v3.19.3
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Thousands
Class A Common Stock
Conversion of Class A-2 to Class A
Class A Common Stock
Conversion of Class B to Class A
Class A Common Stock
Class A-2 Common Stock
Conversion of Class A-2 to Class A
Class A-2 Common Stock
Class B Common Stock
Conversion of Class B to Class A
Class B Common Stock
Conversion of Class B to Class A
Total Stockholders' Equity
Conversion of Class B to Class A
Additional Paid-In Capital
Conversion of Class B to Class A
Noncontrolling Interests
Total Stockholders' Equity
Additional Paid-In Capital
Retained Earnings (Accumulated Deficit)
Accumulated Other Comprehensive Income (Loss)
Noncontrolling Interests
Total
Beginning balance at Dec. 31, 2017     $ 592   $ 67   $ 404       $ 656,647 $ 673,141 $ (17,859) $ 302 $ 406,722 $ 1,063,369
Beginning balance (in shares) at Dec. 31, 2017     59,182,176   6,731,845   40,331,989                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Conversion of common stock $ 67 $ 144   $ (67)   $ (144)   $ 146,865 $ 146,865 $ (146,865)            
Conversion of common stock (in shares) 6,731,839 14,305,146   (6,731,839)   (14,305,146)                    
ESPP shares issued                     99 99     (13) 86
ESPP shares issued (in shares)     6,413                          
Equity-based compensation                     5,543 5,543     2,487 8,030
Issuance of restricted shares     $ 4               2,325 2,321     (2,325)  
Issuance of restricted shares (in shares)     438,182                          
Exercise of restricted stock units                     104 104     (104)  
Exercise of restricted stock units (in shares)     27,860                          
Stock options exercised     $ 1               1,019 1,018     (374) 645
Stock options exercised (in shares)     79,333                          
Repurchase of common stock     $ (1)               (804) (803)     (73) (877)
Repurchase of common stock ( in shares)     (62,777)   (6)                      
Restricted shares forfeited                     (380) (380)     379 (1)
Restricted shares forfeited (in shares)     (49,638)                          
Distributions to noncontrolling interests, net                             (506) (506)
NCI income tax adjustment                     (229) (229)     229  
Foreign currency translation adjustment                     (319)     (319) (176) (495)
Net income                     50,012   50,012   22,409 72,421
Ending balance at Sep. 30, 2018     $ 807       $ 260       861,340 828,137 32,153 (17) 281,332 1,142,672
Ending balance (in shares) at Sep. 30, 2018     80,658,534       26,026,843                  
Beginning balance at Jun. 30, 2018     $ 773       $ 294       800,820 790,699 9,202 (148) 307,991 1,108,811
Beginning balance (in shares) at Jun. 30, 2018     77,298,660       29,383,320                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Conversion of common stock   $ 34       $ (34)   35,062 35,062 (35,062)            
Conversion of common stock (in shares)   3,356,477       (3,356,477)                    
ESPP shares issued                     49 49     (17) 32
ESPP shares issued (in shares)     2,427                          
Equity-based compensation                     1,926 1,926     639 2,565
Issuance of restricted shares                     60 60     (60)  
Issuance of restricted shares (in shares)     7,587                          
Stock options exercised                     643 642     (375) 268
Stock options exercised (in shares)     42,124                          
Repurchase of common stock                     (221) (220)     1 (220)
Repurchase of common stock ( in shares)     (17,743)                          
Restricted shares forfeited                     (310) (310)     309 (1)
Restricted shares forfeited (in shares)     (30,998)                          
Distributions to noncontrolling interests, net                             (226) (226)
NCI income tax adjustment                     229 229     (229)  
Foreign currency translation adjustment                     131     131 45 176
Net income                     22,951   22,951   8,316 31,267
Ending balance at Sep. 30, 2018     $ 807       $ 260       861,340 828,137 32,153 (17) 281,332 1,142,672
Ending balance (in shares) at Sep. 30, 2018     80,658,534       26,026,843                  
Beginning balance at Dec. 31, 2018     $ 790       $ 260       832,934 813,599 18,653 (368) 277,839 $ 1,110,773
Beginning balance (in shares) at Dec. 31, 2018     78,956,555       26,026,843                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Conversion of common stock   $ 75       $ (75)   82,706 82,706 (82,706)            
Conversion of common stock (in shares)   7,564,868       (7,564,868)                   7,564,868
ESPP shares issued                     79 79     1 $ 80
ESPP shares issued (in shares)     8,746                          
Equity-based compensation                     9,045 9,045     2,829 11,874
Issuance of restricted shares     $ 14               3,604 3,590     (3,604)  
Issuance of restricted shares (in shares)     1,391,479                          
Exercise of restricted stock units                     4 4     (4)  
Exercise of restricted stock units (in shares)     1,250                          
Stock options exercised                     84 84     (54) 30
Stock options exercised (in shares)     5,282                          
Repurchase of common stock     $ (16)               (15,902) (15,886)     2,501 (13,401)
Repurchase of common stock ( in shares)     (1,597,150)                          
Restricted shares forfeited                     (36) (36)     36  
Restricted shares forfeited (in shares)     (10,017)                          
Distributions to noncontrolling interests, net                             (349) (349)
NCI income tax adjustment                     (89) (89)     89  
Foreign currency translation adjustment                     387 19   368 85 472
Net income                     12,714   12,714   3,926 16,640
Ending balance at Sep. 30, 2019     $ 863       $ 185       925,708 893,293 31,367   200,411 1,126,119
Ending balance (in shares) at Sep. 30, 2019     86,321,013       18,461,975                  
Beginning balance at Jun. 30, 2019     $ 802       $ 260       848,638 821,968 25,988 (380) 278,210 $ 1,126,848
Beginning balance (in shares) at Jun. 30, 2019     80,176,078       26,026,843                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Conversion of common stock   $ 75       $ (75)   $ 82,706 $ 82,706 $ (82,706)            
Conversion of common stock (in shares)   7,564,868       (7,564,868)                   7,564,868
ESPP shares issued                     21 21     3 $ 24
ESPP shares issued (in shares)     3,079                          
Equity-based compensation                     2,774 2,774     792 3,566
Issuance of restricted shares                     41 41     (41)  
Issuance of restricted shares (in shares)     17,549                          
Stock options exercised                     84 84     (54) 30
Stock options exercised (in shares)     5,282                          
Repurchase of common stock     $ (14)               (14,361) (14,347)     2,476 (11,885)
Repurchase of common stock ( in shares)     (1,444,648)                          
Restricted shares forfeited                     (13) (13)     13  
Restricted shares forfeited (in shares)     (1,195)                          
Distributions to noncontrolling interests, net                             (124) (124)
NCI income tax adjustment                     (40) (40)     40  
Foreign currency translation adjustment                     399 19   $ 380 89 488
Net income                     5,379   5,379   1,793 7,172
Ending balance at Sep. 30, 2019     $ 863       $ 185       $ 925,708 $ 893,293 $ 31,367   $ 200,411 $ 1,126,119
Ending balance (in shares) at Sep. 30, 2019     86,321,013       18,461,975